Screener / SEC EDGAR /CIK 0001788060 /Numbers from the XBRL of the 10-Ks
NYSE Industrials · Defense

Voyager Technologies, Inc. VOYG

Compare with peers Embed
New in the 10-K - fewer than two 10-Ks to compare New in the 10-Q 30 paragraphs not in the 10-Q filed Aug 4, 2026 10-Q against the 10-K 1 risk factor paragraphs and sentences added or reworded

Paragraphs with nothing like them in last year's 10-K

Fewer than two 10-Ks to compare.

Paragraphs in the 10-Q filed Nov 3, 2026 that were not in the one before

New in the latest 10-Q

30 paragraphs in the 10-Q filed Nov 3, 2026 with nothing like them in the 10-Q filed Aug 4, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

(Unaudited, in thousands) September 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025

Read in the 10-Q

limited to, generating revenue from engineering services and product sales to customers and seeking external sources of liquidity via a mix of equity and debt.

Read in the 10-Q

material differences between the estimates and actual results, the Company’s future results of operations could be affected.

Read in the 10-Q

Advanced payments represent amounts paid in advance of the performance of launch services and are presented as separate line items on the condensed consolidated balance sheets, classified as current or non-current based on the expected timing of the underlying launch related to revenue generating programs. Advanced payments are capitalized to the balance sheet and then recognized as a cost of the related program, as applicable, in the period set forth by the underlying terms of the vendor or upon the completion of the associated launch. As of September 30, 2026, the Company had $ 6.0 million of advanced payments classified as current. The Company had no advanced payments as of December 31, 2025.

Read in the 10-Q

On July 10, 2026, the Company acquired 100 % of the equity securities of Astrobotic Technology, Inc. ("Astrobotic") for $ 275.4 million in consideration, which was comprised of $ 96.1 million in cash, $ 63.1 million in equity and $ 116.2 million in contingent consideration. Astrobotic is a key strategic acquisition in the Company's strategic lunar initiative.

Read in the 10-Q
Show the other 25

During the three months ended September 30, 2026 and subsequent to the closing of the acquisition, $ 69.5 million of the contingent consideration was settled in $ 38.2 million of cash and $ 31.3 million of equity. The fair value of the remaining earnout liability balance as of September 30, 2026 was estimated using probability-weighted discounted cash flow models with significant inputs that are not observable in the market and thus represent a Level 3 fair value measurement. The maximum contingent consideration payable remaining as of September 30, 2026 from the Company to Astrobotic is $ 59.3 million.

Read in the 10-Q

The financial information in the table below summarizes the combined results of operations, on a pro forma basis, as though the business combination had occurred as of the earliest period presented. The unaudited pro forma financial information is presented for informational purposes only and are not necessarily indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of January 1, 2025.

Read in the 10-Q

The following unaudited pro forma summary presents consolidated information as if the business combination had occurred on January 1, 2025.

Read in the 10-Q

The unaudited pro forma combined condensed financial information during the three and nine months ended September 30, 2026 were adjusted to include depreciation and amortization adjustments of $ 0.3 million and $ 5.9 million, respectively to reflect the adjustment to property, plant, and equipment depreciation and amortization expense from the acquired developed technology and customer relationships. The unaudited pro forma combined condensed financial information during the three and nine months ended September 30, 2025 were adjusted to include depreciation and amortization adjustments of $ 2.8 million and $ 8.5 million, respectively, to reflect these same adjustments.

Read in the 10-Q

As a result of acquired, existing revenue contracts, in which current estimate of consideration expected to be received is less than the current estimate of total costs, a $ 53.9 million loss provision was assumed as part of the acquisition. Of which, $ 19.9 million is within Accrued expenses and other current liabilities and $ 34.0 million is within Other long-term liabilities presented in the table above.

Read in the 10-Q

Provisional Fair Values of the Assets and Liabilities - ExoTerra & Estes Acquisitions

Read in the 10-Q

(1) Accrued contract provision, current, is primarily associated with new contract loss provisions related to firm-fixed price contracts assumed from the Astrobotic acquisition in July 2026. See "Note 4. Acquisitions," for additional information. The comparative period amount was previously reported within the Other current liabilities line item in the table above.

Read in the 10-Q

A contract loss occurs when the current estimate of the consideration that the Company expects to receive is less than the current estimate of total costs to complete the contract. For purposes of determining the existence of an amount of a contract loss, the Company considers total contract consideration, including any variable consideration constrained for revenue recognition purposes. The Company may experience favorable or unfavorable changes to contract losses from time to time due to EAC adjustments and modifications that result in changes to contract price. The Company recorded immaterial net losses in operations related to contracts with customers for the three and nine months ended September 30, 2026 and for the three and nine months ended September 30, 2025. See Note 4, "Acquisitions" for information related to the contract loss provision acquired during the period ended September 30, 2026.

Read in the 10-Q

The Company’s CODM is the Chief Executive Officer. The CODM uses net sales and Adjusted EBITDA to assess segment performance and make decisions regarding the allocation of capital and other investments. Adjusted

Read in the 10-Q

The Company has evaluated subsequent events through November 3, 2026, the date the condensed consolidated financial statements were issued. There were no material subsequent events which required recognition or additional disclosure.

Read in the 10-Q

Since our founding in 2019, we have deployed first-of-its-kind missile defense maneuvering capabilities, developed groundbreaking space technology, and been selected by NASA to develop a commercial replacement for the ISS. In 2026, we implemented a strategic lunar initiative to build the foundational infrastructure for sustained human and robotic operations on the lunar surface: power distribution, automated logistics, communications and

Read in the 10-Q

compute, and human support systems. We believe Voyager has the most integrated lunar platform in the industry, including a partnership to advance expandable habitat infrastructure and the acquisition of Astrobotic, which brings an end-to-end lunar lander and infrastructure business.

Read in the 10-Q

Other information

The following information is included in this Quarterly Report for the purpose of providing the disclosure required under Item 5.02(e) of Form 8-K, in lieu of filing a Current Report on Form 8-K.

Read in the 10-Q

On November 2, 2026, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Compensation Committee of the Board (the “Committee”), approved the grant of a special, one-time equity award (the “Equity Award”) to our President and Co-Founder, Matthew Kuta (the “Executive”). Following the Board’s review and consideration of various factors, including the significant role the Executive has played in the development and expansion of the Company, the importance of securing the continued leadership of the Executive, the goal to incentivize long-term growth and shareholder value creation and the market data provided by its independent compensation consultant, the Board determined that the grant of the Equity Award to the Executive will be effective on November 9, 2026 and in the form of 1,000,000 performance-based restricted stock units (“PSUs”) and 1,500,000 non-qualified performance-based stock options (“Performance Options”) with an exercise price per share equal to the fair market value of a share of Class A common stock on the date of grant, in each case, in respect of the Company’s Class A common stock, and pursuant to the Company’s 2025 Incentive Award Plan (as may be amended from time to time, the “Plan”), as further described below.

Read in the 10-Q

Vesting of the Equity Award will be contingent on a combination of the achievement of rigorous Market Capitalization Milestones (as defined below) over the eight-year period following the grant date (the “Performance Period”) and the Executive satisfying certain time-based vesting conditions. The Equity Award is designed so that the Executive will realize value only if the Company achieves and sustains substantial increases in its market capitalization over an extended period, and, with respect to the Performance Options, if Company stock price appreciation occurs. The Equity Award is also intended to accelerate the ownership of Company equity by the Executive in relation to the Executive’s existing equity ownership in order to further align his interests with those of our shareholders.

Read in the 10-Q

Each grant of PSUs and Performance Options is divided into nine tranches. A tranche will be earned only if the Company achieves the market capitalization milestone applicable to that tranche (each, a “Market Capitalization Milestone”) during the Performance Period, as set forth in the table below. The Committee may adjust the Market

Read in the 10-Q

Capitalization Milestone thresholds to reflect the impact of any extraordinary transaction, event or development during the Performance Period (including, but not limited to, mergers, acquisitions, stock splits, share repurchases, recapitalizations and reorganizations).

Read in the 10-Q

For purposes of the Equity Award, “market capitalization” on any trading day is defined as the product of (i) the total number of the Company’s shares of Class A common stock and Class B common stock outstanding (on an as-converted basis), as of the close of such trading day, and (ii) the volume-weighted average price per share of the Company’s Class A common stock over 90 consecutive trading days ending on and including such date. In designing the Equity Award, the Board determined that market capitalization was a meaningful and objective performance metric that would measure overall growth and incentivize long-term value creation for the Company and its shareholders.

Read in the 10-Q

A tranche will not be earned unless and until the Committee certifies that the applicable Market Capitalization Milestone has been achieved, which certification is required to occur as soon as practicable following the achievement of the applicable Market Capitalization Milestone, but no later than 60 days following achievement. More than one tranche may be earned on the same date, and no portion of a tranche will be earned for market capitalization achieved between Market Capitalization Milestones. Any tranche that has not been earned by the end of the Performance Period will be forfeited for no consideration.

Read in the 10-Q

In addition to the Market Capitalization Milestones described above, the Equity Award is subject to a three-year service-based cliff vesting requirement (the “Cliff Vest Condition”). Any tranche earned before the third anniversary of the grant date (such three-year period, the “Cliff Vest Period”) will vest immediately following the expiration of the Cliff Vest Period, subject to the Executive’s continued service through such date. Any tranche earned after satisfaction of the Cliff Vest Condition will immediately vest and/or become exercisable, as applicable, on the date the applicable Market Capitalization Milestone is certified by the Committee as being achieved, subject to the Executive’s continued service through such date. As such, other than as described below, no portion of the Equity Award may vest and/or become exercisable, as applicable, prior to satisfaction of the Cliff Vest Condition.

Read in the 10-Q

In the event of the Executive’s termination of service by the Company without “Cause” or by the Executive for “Good Reason” (each as defined in the Executive’s employment agreement) prior to satisfaction of the Cliff Vest Condition, and subject to the Executive’s execution and non-revocation of a general release of claims in favor of the Company (a “Release”), any PSUs and Performance Options not yet earned will remain outstanding and eligible to be earned, in each case, based upon achievement of the applicable Market Capitalization Milestones through the later of the expiration of the Cliff Vest Period and the first anniversary of the termination date, without regard to continued service. Notwithstanding the foregoing, in the event of such termination, no portion of the PSUs or Performance Options (including any portion earned during the Cliff Vest Period prior to such termination) will become vested and/or exercisable, as applicable, until the expiration of the Cliff Vest Period.

Read in the 10-Q

In the event of the Executive’s termination of service due to the Executive’s death or “Disability” (as defined in the Executive’s employment agreement), and subject to the Executive’s (or the Executive’s estate’s) execution and non-revocation of a Release, (i) any tranche that has been earned prior to such termination but which remains subject

Read in the 10-Q

to the Cliff Vest Condition will vest in full and become exercisable, as applicable, as of such termination date and (ii) any tranche not yet earned will remain outstanding through the first anniversary of such termination date and will be eligible to be earned, vested and/or become exercisable, as applicable, upon achievement of the applicable Market Capitalization Milestone, without regard to continued service.

Read in the 10-Q

If a “Change in Control” (as defined in the Plan) of the Company occurs during the Performance Period, achievement of the Market Capitalization Milestones will be measured using the per share price paid to the Company’s shareholders in the Change in Control. Each tranche for which the applicable Market Capitalization Milestone is achieved will vest in full upon the Change in Control, without regard to the Cliff Vest Condition, and each tranche for which the applicable Market Capitalization Milestone is not achieved will be forfeited for no consideration.

Read in the 10-Q

The foregoing description of the Equity Award is qualified in its entirety by reference to the full text of the applicable award agreements, the forms of which are filed as Exhibits 10.4 and 10.5 to this Quarterly Report and incorporated by reference herein.

Read in the 10-Q

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Nov 3, 2026 against Item 1A of the 10-K filed Mar 10, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted). Text on the page, not a score; each links to the filing at sec.gov.

Added10-Q Nov 3, 2026 vs 10-K Mar 10, 2026
Our business, financial condition and operating results can be affected by a number of factors, including but not limited to those described as risk factors, any one or more of which could, directly or indirectly, cause our actual operating results and financial condition to vary materially from past, or anticipated future, operating results and financial condition. For a discussion of these potential risks and uncertainties, see the section entitled “Risk Factors” in our Form 10-K, which risk factors are incorporated herein by reference. Any of these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and the price of our common stock. There have been no material changes in our risk factors to those included in our Form 10-K.

Read it in the 10-Q at sec.gov

Sources

Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.

Also

10-K change: what was reworded or cut, section by section.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VOYG/export.csv") into a cell.

Next:10-K change
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.